Discipline of Life Science, Institute of Innovation, Science and Sustainability, Federation University Australia, University Drive, Mt Helen, Ballarat, VIC, 3350, Australia.
Molecular Biomedicine Theme, Faculty of Medicine and Health, Charles Perkins Centre, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.
Sci Rep. 2023 Jan 28;13(1):1614. doi: 10.1038/s41598-023-28738-2.
We investigated the association of dietary intake of major types of fatty acids with heart disease mortality in a general adult cohort with or without a prior diagnosis of myocardial infarction (MI). This cohort study included US adults who attended the National Health and Nutrition Examination Surveys from 1988 to 2014. Heart disease mortality was ascertained by linkage to the National Death Index records through 31 December 2015. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of fatty acid intake for heart disease mortality. This cohort included 45,820 adults among which 1,541 had a prior diagnosis of MI. Participants were followed up for 532,722 person-years (mean follow-up, 11.6 years), with 2,313 deaths recorded from heart disease being recorded. Intake of saturated (SFAs) and monounsaturated fatty acids (MUFAs) was associated with heart disease mortality after adjustment for all the tested confounders. In contrast, a 5% higher calorie intake from polyunsaturated fatty acids (PUFAs) was associated with a 9% (HR, 0.91; 95% CI 0.83-1.00; P = 0.048) lower multivariate-adjusted risk of heart disease mortality. Sub-analyses showed that this inverse association was present in those without a prior diagnosis of MI (HR,0.89; 95% CI 0.80-0.99) but not in those with the condition (HR, 0.94; 95% CI 0.75-1.16). The lack of association in the MI group could be due to a small sample size or severity and procedural complications (e.g., stenting and medication adherence) of the disease. Higher PUFA intake was associated with a favourable lipid profile. However, further adjustment for plasma lipids did not materially change the inverse association between PUFAs and heart disease mortality. Higher intake of PUFAs, but not SFAs and MUFAs, was associated with a lower adjusted risk of heart disease mortality in a large population of US adults supporting the need to increase dietary PUFA intake in the general public.
我们研究了在一般成年队列中,主要类型的脂肪酸的饮食摄入量与是否有心肌梗死(MI)既往诊断与心脏病死亡率的关系。这项队列研究包括了参加 1988 年至 2014 年国家健康和营养调查的美国成年人。通过与国家死亡索引记录的链接,在 2015 年 12 月 31 日之前确定心脏病死亡率。使用 Cox 比例风险模型估计脂肪酸摄入与心脏病死亡率的危险比(HR)和 95%置信区间(CI)。该队列包括 45820 名成年人,其中 1541 人有 MI 既往诊断。参与者的随访时间为 532722 人年(平均随访时间 11.6 年),记录了 2313 例心脏病死亡。在调整了所有测试的混杂因素后,饱和脂肪酸(SFAs)和单不饱和脂肪酸(MUFAs)的摄入与心脏病死亡率有关。相比之下,多不饱和脂肪酸(PUFAs)的卡路里摄入量增加 5%,与心脏病死亡率的多变量调整风险降低 9%(HR,0.91;95%CI,0.83-1.00;P=0.048)相关。亚分析表明,这种反比关系存在于没有 MI 既往诊断的人群中(HR,0.89;95%CI,0.80-0.99),但在有该疾病的人群中则不存在(HR,0.94;95%CI,0.75-1.16)。MI 组中没有关联可能是由于该组样本量较小或疾病的严重程度和程序并发症(例如,支架和药物依从性)所致。较高的 PUFAs 摄入量与有利的血脂谱有关。然而,进一步调整血浆脂质并没有实质上改变 PUFAs 与心脏病死亡率之间的反比关系。在一个大型的美国成年人队列中,较高的 PUFAs 摄入量与调整后的心脏病死亡率降低相关,而 SFAs 和 MUFAs 则不然,这支持了在普通人群中增加饮食中 PUFAs 摄入量的必要性。